| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| RPIDRapid Micro Biosystems, Inc. | 121.06M | 3.04 | -2.81 | 24.57% | -145.11% | -99.91% | 0.08 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 16.51M | 16.08M | 23.23M | 17.13M | 22.52M | 28.05M |
| Revenue Growth % | - | -0.03% | 0.45% | -0.26% | 0.31% | 0.25% |
| Cost of Goods Sold | 16.75M | 24.15M | 30.97M | 25.67M | 28M | 28.16M |
| COGS % of Revenue | 1.01% | 1.5% | 1.33% | 1.5% | 1.24% | 1% |
| Gross Profit | -234K | -8.07M | -7.74M | -8.54M | -5.49M | -109K |
| Gross Margin % | -0.01% | -0.5% | -0.33% | -0.5% | -0.24% | -0% |
| Gross Profit Growth % | - | -33.49% | 0.04% | -0.1% | 0.36% | 0.98% |
| Operating Expenses | 18.4M | 22.47M | 39.49M | 54.68M | 51.08M | 49.81M |
| OpEx % of Revenue | 1.11% | 1.4% | 1.7% | 3.19% | 2.27% | 1.78% |
| Selling, General & Admin | 12.97M | 15.94M | 29.71M | 41.81M | 38.26M | 35.21M |
| SG&A % of Revenue | 0.79% | 0.99% | 1.28% | 2.44% | 1.7% | 1.26% |
| Research & Development | 5.43M | 6.53M | 9.78M | 12.87M | 12.82M | 14.6M |
| R&D % of Revenue | 0.33% | 0.41% | 0.42% | 0.75% | 0.57% | 0.52% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.63M | -30.54M | -47.23M | -63.22M | -56.56M | -49.92M |
| Operating Margin % | -1.13% | -1.9% | -2.03% | -3.69% | -2.51% | -1.78% |
| Operating Income Growth % | - | -0.64% | -0.55% | -0.34% | 0.11% | 0.12% |
| EBITDA | -17.13M | -29.04M | -45.7M | -60.38M | -53.46M | -46.56M |
| EBITDA Margin % | -1.04% | -1.81% | -1.97% | -3.52% | -2.37% | -1.66% |
| EBITDA Growth % | - | -0.69% | -0.57% | -0.32% | 0.11% | 0.13% |
| D&A (Non-Cash Add-back) | 1.5M | 1.5M | 1.53M | 2.84M | 3.1M | 3.36M |
| EBIT | -18.37M | -33.5M | -47.23M | -63.22M | -56.56M | -49.92M |
| Net Interest Income | -2.38M | -3.45M | -2.65M | 1.78M | 4.21M | 3.16M |
| Interest Income | 0 | 0 | 0 | 1.78M | 4.21M | 3.16M |
| Interest Expense | 2.38M | 3.45M | 2.65M | 0 | 0 | 0 |
| Other Income/Expense | -2.11M | -6.4M | -26.2M | 1.84M | 4.13M | 3.05M |
| Pretax Income | -20.74M | -36.94M | -73.43M | -61.38M | -52.44M | -46.87M |
| Pretax Margin % | -1.26% | -2.3% | -3.16% | -3.58% | -2.33% | -1.67% |
| Income Tax | 427K | 134K | 91K | -576K | 31K | 22K |
| Effective Tax Rate % | 1.02% | 1% | 1% | 0.99% | 1% | 1% |
| Net Income | -21.17M | -37.08M | -73.52M | -60.81M | -52.47M | -46.89M |
| Net Margin % | -1.28% | -2.31% | -3.16% | -3.55% | -2.33% | -1.67% |
| Net Income Growth % | - | -0.75% | -0.98% | 0.17% | 0.14% | 0.11% |
| Net Income (Continuing) | -21.17M | -37.08M | -73.52M | -60.81M | -52.47M | -46.89M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.53 | -1.17 | -1.88 | -1.43 | -1.22 | -1.08 |
| EPS Growth % | - | -1.21% | -0.61% | 0.24% | 0.15% | 0.11% |
| EPS (Basic) | -0.53 | -1.17 | -1.88 | -1.43 | -1.22 | -1.08 |
| Diluted Shares Outstanding | 39.66M | 38.67M | 41.47M | 42.45M | 43.02M | 43.58M |
| Basic Shares Outstanding | 39.66M | 38.67M | 41.47M | 42.45M | 43.02M | 43.58M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 23.61M | 62.15M | 218.12M | 138.58M | 120.42M | 80.92M |
| Cash & Short-Term Investments | 12.46M | 45.08M | 193.5M | 108.65M | 92.05M | 50.73M |
| Cash Only | 12.46M | 30.08M | 178.39M | 27.06M | 24.29M | 16.91M |
| Short-Term Investments | 0 | 15M | 15.11M | 81.58M | 67.77M | 33.82M |
| Accounts Receivable | 4.92M | 5.78M | 5.63M | 5.48M | 5.58M | 7.53M |
| Days Sales Outstanding | 108.74 | 131.32 | 88.48 | 116.77 | 90.49 | 97.92 |
| Inventory | 5.75M | 8.96M | 15.67M | 21.19M | 19.96M | 20.2M |
| Days Inventory Outstanding | 125.37 | 135.51 | 184.67 | 301.22 | 260.17 | 261.83 |
| Other Current Assets | 336K | 546K | 440K | 705K | 577K | 843K |
| Total Non-Current Assets | 8.08M | 7.85M | 23.05M | 52.07M | 23.04M | 17.25M |
| Property, Plant & Equipment | 7.59M | 7.05M | 11.3M | 20.88M | 19.07M | 16.36M |
| Fixed Asset Turnover | 2.17x | 2.28x | 2.06x | 0.82x | 1.18x | 1.72x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 152K | 0 | 9.97M | 29.79M | 2.91M | 365K |
| Other Non-Current Assets | 332K | 795K | 1.77M | 1.4M | 1.05M | 531K |
| Total Assets | 31.69M | 70M | 241.17M | 190.65M | 143.45M | 98.17M |
| Asset Turnover | 0.52x | 0.23x | 0.10x | 0.09x | 0.16x | 0.29x |
| Asset Growth % | - | 1.21% | 2.45% | -0.21% | -0.25% | -0.32% |
| Total Current Liabilities | 10.53M | 15.54M | 18.17M | 19.05M | 18.99M | 17.57M |
| Accounts Payable | 3.21M | 4.47M | 3.94M | 5.43M | 1.97M | 2.54M |
| Days Payables Outstanding | 69.99 | 67.53 | 46.48 | 77.17 | 25.72 | 32.86 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 1.21M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 2.58M | 2.88M | 4.04M | 3.74M | 4.95M | 4.62M |
| Current Ratio | 2.24x | 4.00x | 12.01x | 7.27x | 6.34x | 4.61x |
| Quick Ratio | 1.70x | 3.42x | 11.14x | 6.16x | 5.29x | 3.46x |
| Cash Conversion Cycle | 164.12 | 199.29 | 226.68 | 340.82 | 324.95 | 326.88 |
| Total Non-Current Liabilities | 21.89M | 29.63M | 2.02M | 7.43M | 6.48M | 5.25M |
| Long-Term Debt | 17.81M | 24.81M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 7.2M | 6.21M | 4.95M |
| Deferred Tax Liabilities | -683K | -705K | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4.08M | 4.82M | 2.02M | 229K | 263K | 298K |
| Total Liabilities | 32.41M | 45.18M | 20.19M | 26.48M | 25.46M | 22.82M |
| Total Debt | 17.81M | 24.81M | 0 | 7.97M | 7.35M | 6.17M |
| Net Debt | 5.35M | -5.27M | -178.39M | -19.1M | -16.94M | -10.74M |
| Debt / Equity | - | 1.00x | - | 0.05x | 0.06x | 0.08x |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -7.85x | -8.86x | -17.82x | - | - | - |
| Total Equity | -725K | 24.82M | 220.98M | 164.17M | 117.99M | 75.35M |
| Equity Growth % | - | 35.23% | 7.9% | -0.26% | -0.28% | -0.36% |
| Book Value per Share | -0.02 | 0.64 | 5.33 | 3.87 | 2.74 | 1.73 |
| Total Shareholders' Equity | -725K | 24.82M | 220.98M | 164.17M | 117.99M | 75.35M |
| Common Stock | 4K | 6K | 415K | 421K | 424K | 430K |
| Retained Earnings | -204.51M | -241.59M | -315.11M | -375.92M | -428.38M | -475.27M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 1K | -16K | -1.11M | -101K | 39K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -21.15M | -31M | -54.96M | -58.55M | -45.08M | -44.15M |
| Operating CF Margin % | -1.28% | -1.93% | -2.37% | -3.42% | -2% | -1.57% |
| Operating CF Growth % | - | -0.47% | -0.77% | -0.07% | 0.23% | 0.02% |
| Net Income | -21.17M | -37.08M | -73.52M | -60.81M | -52.47M | -46.89M |
| Depreciation & Amortization | 1.46M | 1.51M | 1.53M | 2.84M | 3.1M | 3.36M |
| Stock-Based Compensation | 473K | 533K | 1.84M | 4.02M | 4.75M | 0 |
| Deferred Taxes | -249K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 449K | 5.14M | 23.19M | 728K | -1.02M | 4.14M |
| Working Capital Changes | -2.11M | -1.1M | -8M | -5.33M | 555K | -4.77M |
| Change in Receivables | -511K | -1.36M | -17K | -364K | -163K | -1.99M |
| Change in Inventory | -3.92M | -3.37M | -6.77M | -5.84M | 1.19M | -335K |
| Change in Payables | 1.03M | 978K | -524K | 1.48M | -3.46M | 562K |
| Cash from Investing | -1.7M | -15.67M | -13.29M | -93.47M | 42.15M | 36.66M |
| Capital Expenditures | -1.7M | -690K | -3.22M | -6.74M | -1.84M | -1.36M |
| CapEx % of Revenue | 0.1% | 0.04% | 0.14% | 0.39% | 0.08% | 0.05% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 20K | 0 | 0 | 0 |
| Cash from Financing | 14.87M | 64.23M | 216.75M | 693K | 149K | 203K |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 0 | -2.2M | -940K | 726K | 186K | 0 |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -22.84M | -31.69M | -58.18M | -65.29M | -46.93M | -45.52M |
| FCF Margin % | -1.38% | -1.97% | -2.5% | -3.81% | -2.08% | -1.62% |
| FCF Growth % | - | -0.39% | -0.84% | -0.12% | 0.28% | 0.03% |
| FCF per Share | -0.58 | -0.82 | -1.40 | -1.54 | -1.09 | -1.04 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.84x | 0.75x | 0.96x | 0.86x | 0.94x |
| Interest Paid | 0 | 1.98M | 2.59M | 42K | 38K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -307.77% | -59.82% | -31.58% | -37.19% | -48.5% |
| Return on Invested Capital (ROIC) | -302.37% | -189.51% | -114.01% | -50.53% | -34.47% | -45.2% |
| Gross Margin | -1.42% | -50.2% | -33.32% | -49.85% | -24.36% | -0.39% |
| Net Margin | -128.22% | -230.63% | -316.48% | -354.91% | -232.99% | -167.16% |
| Debt / Equity | - | 1.00x | - | 0.05x | 0.06x | 0.08x |
| Interest Coverage | -7.85x | -8.86x | -17.82x | - | - | - |
| FCF Conversion | 1.00x | 0.84x | 0.75x | 0.96x | 0.86x | 0.94x |
| Revenue Growth | - | -2.63% | 44.5% | -26.25% | 31.44% | 24.57% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Product | - | 11.06M | 20.06M | 21.04M |
| Product Growth | - | - | 81.44% | 4.89% |
| Service | - | 6.08M | 7.94M | 9.32M |
| Service Growth | - | - | 30.72% | 17.36% |
| Government Contract | - | - | - | - |
| Government Contract Growth | - | - | - | - |
| Product and service revenue - non-recurring | 13.82M | - | - | - |
| Product and service revenue - non-recurring Growth | - | - | - | - |
| Product and service revenue - recurring | 7.82M | - | - | - |
| Product and service revenue - recurring Growth | - | - | - | - |
| Non-commercial revenue - non-recurring | 1.59M | - | - | - |
| Non-commercial revenue - non-recurring Growth | - | - | - | - |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| UNITED STATES | - | 8.77M | 9.88M | 10.64M |
| UNITED STATES Growth | - | - | 12.68% | 7.69% |
| All Other Countries | - | 2.96M | 3.97M | 6.64M |
| All Other Countries Growth | - | - | 33.98% | 67.43% |
| SWITZERLAND | - | 2.76M | 4M | 5.67M |
| SWITZERLAND Growth | - | - | 44.96% | 41.88% |
| GERMANY | - | 2.65M | 2.12M | 3.05M |
| GERMANY Growth | - | - | -20.12% | 44.09% |
| JAPAN | - | - | 2.56M | 2.05M |
| JAPAN Growth | - | - | - | -19.87% |
| United states | 12.89M | - | - | - |
| United states Growth | - | - | - | - |
| All other countries | 4.33M | - | - | - |
| All other countries Growth | - | - | - | - |
| Switzerland | 4.31M | - | - | - |
| Switzerland Growth | - | - | - | - |
| Germany | 1.7M | - | - | - |
| Germany Growth | - | - | - | - |
Rapid Micro Biosystems, Inc. (RPID) reported $30.5M in revenue for fiscal year 2024. This represents a 85% increase from $16.5M in 2019.
Rapid Micro Biosystems, Inc. (RPID) grew revenue by 24.6% over the past year. This is strong growth.
Rapid Micro Biosystems, Inc. (RPID) reported a net loss of $44.3M for fiscal year 2024.
Rapid Micro Biosystems, Inc. (RPID) has a return on equity (ROE) of -48.5%. Negative ROE indicates the company is unprofitable.
Rapid Micro Biosystems, Inc. (RPID) had negative free cash flow of $38.6M in fiscal year 2024, likely due to heavy capital investments.